Barbara Miziak

Lublin, LU 20090, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Selected Molecular Targets for Counteracting Epileptogenesis: What Do We Know About Its Effective Inhibition?

Selected Molecular Targets for Counteracting Epileptogenesis: What Do We Know About Its Effective Inhibition?

Journal: Current issues in molecular biology

Published: July 06, 2026

Non-Pharmacological Treatment Methods of Lennox-Gastaut Syndrome-Review of the Literature.

Non-Pharmacological Treatment Methods of Lennox-Gastaut Syndrome-Review of the Literature.

Journal: Biomedicines

Published: July 23, 2025

The Oxidative Stress in Epilepsy-Focus on Melatonin.

The Oxidative Stress in Epilepsy-Focus on Melatonin.

Journal: International journal of molecular sciences

Published: October 25, 2024

Cenobamate, a New Promising Antiseizure Medication: Experimental and Clinical Aspects.

Cenobamate, a New Promising Antiseizure Medication: Experimental and Clinical Aspects.

Journal: International journal of molecular sciences

Published: October 18, 2024

Methionine Sulfoximine as a Tool for Studying Temporal Lobe Epilepsy: Initiator, Developer, Attenuator.

Methionine Sulfoximine as a Tool for Studying Temporal Lobe Epilepsy: Initiator, Developer, Attenuator.

Journal: Neurochemical research

Published: October 15, 2024

Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.

Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.

Journal: Journal of Alzheimer's disease : JAD

Published: February 23, 2024

Caffeine and Its Interactions with Antiseizure Medications-Is There a Correlation between Preclinical and Clinical Data?

Caffeine and Its Interactions with Antiseizure Medications-Is There a Correlation between Preclinical and Clinical Data?

Journal: International journal of molecular sciences

Published: October 27, 2023

Editorial: Epilepsy and endocrine function.

Editorial: Epilepsy and endocrine function.

Journal: Frontiers in endocrinology

Published: September 04, 2023

Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.

Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.

Journal: Molecules (Basel, Switzerland)

Published: June 30, 2023

Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.

Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.

Journal: International journal of molecular sciences

Published: May 21, 2023

Second Generation of Antiepileptic Drugs and Oxidative Stress.

Second Generation of Antiepileptic Drugs and Oxidative Stress.

Journal: International journal of molecular sciences

Published: December 27, 2022

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.

Journal: Expert opinion on drug discovery

Published: November 21, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026